Please login to the form below

Not currently logged in
Email:
Password:

Britannia promotes Robert Wood

He takes up new marketing director role

Britannia_Robert_WoodBritannia Pharmaceuticals has promoted Robert Wood to marketing director, for international markets.

Wood was previously director partners, EMEA at Britannia and has 15 years experience in the life science and pharmaceutical industries.

Prior to joining Britannia, which is part of Stada, in early 2011, his roles included business unit director, pharmaceuticals at International SOS and vice president of business development at Optasia Medical.

Britannia Pharmaceuticals has been working in Parkinson's disease for over thirty years and its APO-go product range is licensed in almost 40 countries.

Wood said: “I am delighted to be continuing to work with Britannia Pharmaceuticals in this new global role, particularly at this incredibly interesting time for the APO-go therapy.

“The initiation of clinical trials to increase the evidence base for both motor and non-motor effects of APO-go in Parkinson's disease and the development of new delivery devices, mean APO-go will provide an excellent treatment option for many more people with Parkinson's.”

3rd May 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics